Biostar Pharmaceuticals, Inc.
BSPMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$264
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Biostar Pharmaceuticals, Inc. (BSPM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BSPM · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2016-12 | 2015-12 | 2014-12 | 2013-12 | 2012-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.38M | $27.13M | $61.42M | $52.73M | $49.32M |
| Cost of Revenue | $1.47M | $16.03M | $31.14M | $27.05M | $19.47M |
| Gross Profit | $0.92M | $11.10M | $30.28M | $25.68M | $29.85M |
| Gross Margin %(computed) | 38.39% | 40.93% | 49.30% | 48.71% | 60.53% |
| Operating Expenses | |||||
| R&D Expenses | $1.14M | $4.02M | $2.77M | $3.23M | $4.48M |
| G&A Expenses | $2.43M | $4.65M | $7.72M | $6.09M | $5.95M |
| Total Operating Expenses | $4.48M | $34.86M | $31.59M | $24.61M | $41.99M |
| Operating Income | ($3.56M) | ($23.76M) | ($1.31M) | $0.51M | ($20.18M) |
| Operating Margin %(computed) | -149.50% | -87.57% | -2.14% | 0.96% | -40.93% |
| Interest Income | $0.00M | $0.01M | $1.33M | $1.34M | $0.30M |
| Interest Expense | $0.21M | $0.28M | $0.15M | $0.37M | $0.08M |
| Income Before Tax | ($3.04M) | ($23.79M) | $1.53M | $2.66M | ($21.57M) |
| Income Tax Expense | $2.65M | $1.32M | ($3.31M) | $1.85M | ($1.58M) |
| Net Income | ($5.70M) | ($25.11M) | $4.85M | $0.81M | ($20.00M) |
| Net Margin %(computed) | -239.01% | -92.57% | 7.89% | 1.53% | -40.55% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.50 | $-11.36 | $2.30 | $0.49 | $-14.63 |
| Wtd Avg Shares | 2.30M | 2.21M | 2.07M | 1.64M | 1.37M |
| EBITDA | ($1.70M) | ($21.19M) | $4.78M | $5.81M | ($19.66M) |
| EBITDA Margin %(computed) | -71.18% | -78.10% | 7.77% | 11.02% | -39.87% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Biostar Pharmaceuticals, Inc. data
About Biostar Pharmaceuticals, Inc. (BSPM) Income Statement
Biostar Pharmaceuticals, Inc. (BSPM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2016, BSPM reported revenue of $0.00B, gross profit of $0.00B (gross margin 38.39%), and net income of ($0.01B) — a net profit margin of -239.01%.
Frequently asked questions
BSPM · 4 questionsBiostar Pharmaceuticals, Inc. (BSPM) reported revenue of $0.00B for 2016, down 91.2% year-over-year.
BSPM revenueBSPM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09